SNOA
- Sonoma Pharmaceuticals, Inc.
()
Overview
Company Summary
Sonoma Pharmaceuticals, Inc. (SNOA) is a specialty pharmaceutical company that focuses on developing and commercializing innovative solutions to address various dermatological conditions and skin diseases. The company primarily specializes in creating and marketing products for the treatment of dermatological conditions such as acne, atopic dermatitis, and seborrheic dermatitis.
Sonoma Pharmaceuticals primarily operates through a business model that involves using its proprietary Microcyn technology. This technology enables the company to develop and produce a wide range of products, including therapeutic solutions, disinfectants, and wound care products.
The company's flagship product line, Microcyn, is a patented and FDA-cleared hypochlorous acid-based solution. This solution has been widely recognized for its unique properties in effectively treating and managing various skin disorders and infections. Sonoma Pharmaceuticals offers various Microcyn-based formulations that cater to multiple dermatological needs, including wound care, eye care, irrigation, and nasal care.
In addition to its Microcyn-based products, Sonoma Pharmaceuticals also develops and markets other prescription and over-the-counter dermatological treatments. These include products for reducing itching and inflammation, managing fungal infections, and addressing other skin-related issues.
The company primarily serves healthcare professionals, including dermatologists, plastic surgeons, wound care specialists, and primary care physicians. They also work towards expanding their distribution network to ensure their products are accessible to patients worldwide.
Overall, Sonoma Pharmaceuticals focuses on developing and providing innovative dermatological solutions to improve patient outcomes and quality of life by addressing a wide range of skin conditions and disorders.